Researcher Profile Form First National Pediatric Brain Tumor Research Meeting March 9, 2025 - Jerusalem
Researcher: Prof. Max Herzberg
Current Role & Affiliation
Title/Position: CEO; Founder and Chairperson of the Board
Institution: Vidac Pharma
Email: maxherzberg@vidacpharma.com
Phone: 054-4257381
Prof. Herzberg is the Founder and Chairperson of Vidac Pharma and a leading figure in the Israeli life sciences industry.
Research Focus
● Molecular biology
● Biotechnology entrepreneurship
● Drug development strategies
Current Projects Related to Pediatric Brain Tumors
● Development of novel therapeutic strategies for cancer treatment
Laboratory/Research Resources
● Biotechnology research platforms
● Drug development expertise
Collaboration Interests
● Drug discovery and development
● Molecular research applications
What You Can Offer Potential Collaborators
● Extensive experience in molecular biology and biotechnology
● Support for drug development initiatives
Recent Relevant Publications
1. Herzberg M, et.al. A novel chemical entity, that reverses Warburg metabolism by disrupting VDAC1/HK2 interaction through “Toposteric Effect” in Cancer.
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://assets-eu.researchsquare.com/files/rs-4382720/v1/29b00673-423f-4b97-bfbc-6ab52e4c7ec1.pdf?c=1717522537
2. Behar V, et.al. A Hexokinase 2 Modulator for Field-Directed Treatment of Experimental Actinic Keratoses. J Invest Dermatol . 2018 Dec;138(12):2635-2643.
Keywords
Molecular Biology, Drug Development, Biotechnology, Entrepreneurship, Varburg Effect
Brief Bio
Prof. Max Herzberg, the Founder and Chairperson of the Board of Vidac Pharma, is a renowned scientist and entrepreneur . Prof. Herzberg founded Orgenics and the EagerBio Group, is the co-founder of PixCell, and served as chairperson of several Israeli biotechnology companies and as chairperson of the European Molecular Biology Laboratory Enterprise Management (Heidelberg, Germany). Prof. Herzberg holds a Ph.D. in Molecular Biology from the Weizmann Institute of Science
